[go: up one dir, main page]

AU7854094A - Use of amiodarone for the treatment of heart failure - Google Patents

Use of amiodarone for the treatment of heart failure

Info

Publication number
AU7854094A
AU7854094A AU78540/94A AU7854094A AU7854094A AU 7854094 A AU7854094 A AU 7854094A AU 78540/94 A AU78540/94 A AU 78540/94A AU 7854094 A AU7854094 A AU 7854094A AU 7854094 A AU7854094 A AU 7854094A
Authority
AU
Australia
Prior art keywords
amiodarone
treatment
heart failure
heart
failure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78540/94A
Inventor
Guillermo Bortman
Rodolfo Curiel
Hernan Doval
Hugo Grancelli
Daniel Nul
Sergio Perrone
Angel Omar Scapin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Handforth Investments Ltd
Original Assignee
Handforth Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Handforth Investments Ltd filed Critical Handforth Investments Ltd
Publication of AU7854094A publication Critical patent/AU7854094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU78540/94A 1993-10-04 1994-09-30 Use of amiodarone for the treatment of heart failure Abandoned AU7854094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP93116013 1993-10-04
EP93116013 1993-10-04
PCT/EP1994/003267 WO1995009625A1 (en) 1993-10-04 1994-09-30 Use of amiodarone for the treatment of heart failure

Publications (1)

Publication Number Publication Date
AU7854094A true AU7854094A (en) 1995-05-01

Family

ID=8213319

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78540/94A Abandoned AU7854094A (en) 1993-10-04 1994-09-30 Use of amiodarone for the treatment of heart failure

Country Status (3)

Country Link
AU (1) AU7854094A (en)
IL (1) IL111144A0 (en)
WO (1) WO1995009625A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4777896A (en) * 1995-02-10 1996-08-27 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease
NZ305528A (en) * 1995-02-10 2001-05-25 G Combination of angiotensin converting enzyme inhibitor and an aldosterone antagonist
FR2735365B1 (en) * 1995-06-14 1997-09-05 Sanofi Sa USE OF AN ANGIOTENSIN II ANTAGONIST AND A BENZOFURANE DERIVATIVE FOR THE PREPARATION OF A MEDICAMENT USEFUL IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS
FR2746013B1 (en) * 1996-03-18 1998-05-29 Sanofi Sa USE OF ANTIARRHYTHMIC COMPOUNDS IN THE PREVENTION OF POST INFARCT MORTALITY
FR2760364A1 (en) * 1997-03-10 1998-09-11 Sanofi Sa USE OF ANTIARRHYTHMIC COMPOUNDS FOR REDUCING MORTALITY AFTER MYOCARDIAL INFARCTION
US6048874A (en) * 1999-01-26 2000-04-11 Medeva Pharmaceuticals Manufacturing, Inc. Parenteral metolazone formulations
CN102423305A (en) * 2011-12-23 2012-04-25 中国药科大学 Isosorbide mononitrate micro-porous osmotic pump tablet and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2626176A1 (en) * 1988-01-25 1989-07-28 Baligadoo Soorianarain Cardioprotective medicinal preparations comprising amiodarone, a nitro derivative and optionally a beta-blocker
US4931464A (en) * 1989-02-15 1990-06-05 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
EP0413694B1 (en) * 1989-02-20 1993-05-12 BALIGADOO, Soorianarain Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker

Also Published As

Publication number Publication date
WO1995009625A1 (en) 1995-04-13
IL111144A0 (en) 1994-12-29

Similar Documents

Publication Publication Date Title
AU7545594A (en) Implantable device for the treatment of aedemas
AU2484692A (en) Cardiac arrest treatment
AU665899B2 (en) Artificial heart
AU2093392A (en) Treatment of congestive heart failure
AU6316794A (en) Medical stent
AU7567394A (en) Treatment chamber catheter
AU3802493A (en) Surgical endoclip
AU1966992A (en) Skin treatment system
AU4944093A (en) Osteosynthesis aid
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
AU7045594A (en) Surgical stockinette
AU6801694A (en) The treatment of small animals
AU3625295A (en) Low profile defibrillation catheter
AU1115095A (en) Treatment of cellulose
AU6253094A (en) Methods for the treatment of osteoporosis
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU4705193A (en) Medicaments for the treatment or prevention of elevated intraocular pressure
AU7421391A (en) Patient hoists
AU2807492A (en) Use of misoprostol for the treatment of allergy
AU2806692A (en) Medicament for the treatment of anxiety
AU7854094A (en) Use of amiodarone for the treatment of heart failure
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU1650792A (en) Treatment of polyurethane surfaces
AU5340594A (en) Skin treatment